Qingdao Kangjing Marine Biotechnology

Qingdao Kangjing Marine Biotechnology is a Chinese biopharmaceutical company dedicated to the exploration and utilization of marine biological resources for human health. Based in the Qingdao Blue Silicon Valley, the company specializes in the research and development of marine-derived oligosaccharides and polysaccharides using advanced enzymatic degradation technologies. Their primary therapeutic focus includes neurodegenerative diseases, such as Alzheimer's, and metabolic disorders like hyperlipidemia and diabetes. The company maintains a close strategic partnership with the Marine Biomedical Research Institute of Qingdao and the Ocean University of China to facilitate the translation of marine science into clinical therapies. In addition to its drug pipeline, Kangjing produces high-end marine-based functional health products and pharmaceutical intermediates under GMP standards.